Dishman Carbogen Amcis Limited (NSE:DCAL)
259.70
-3.33 (-1.27%)
Jan 8, 2026, 3:29 PM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 40.61 billion as of January 8, 2026. Its market cap has decreased by -6.30% in one year.
Market Cap
40.61B
Enterprise Value
59.89B
Revenue
27.59B
Ranking
n/a
PE Ratio
29.78
Stock Price
259.70
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 40.61B, a decrease of -28.52%. That is a compound annual growth rate of -3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 41.24B | 6.24% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |